Clinical Trials Network

Our Vision

The CTN will take a leadership role in advancing the use of radiopharmaceuticals and optimizing the use of molecular imaging in clinical trials and dissemination into clinical practice.

Mission

Facilitate the effective use of molecular imaging in clinical trials through standardization, coordination, and education for drug development and regulatory approval.

The CTN updated their Strategic Plan in 2013 to reflect the evolving needs of the community and changes in clinical trials and the regulatory environment. Our key goals are to:

  1. Ensure high-quality PET and SPECT imaging in the conduct of drug development clinical trials
  2. Work towards use and approval of new radiopharmaceuticals
  3. Facilitate access to investigational PET radiopharmaceuticals for multicenter clinical trials
  4. Provide education and training for the use of molecular imaging in clinical research
  5. Expand the depth of leadership, committee membership, and possibly technical staff personnel

The Clinical Trials Network (CTN) was formed in 2008 by SNMMI to help facilitate the effective use of molecular imaging radiopharmaceuticals in clinical trials. Our Mission is to facilitate the effective use of MI in clinical trials through standardization, coordination, and education for drug development and regulatory approval.

We also maintain a comprehensive database that stores and manages information on imaging sites, production sites, and those sites that have both imaging and production capabilities. To date, we have over 500 sites registered in the CTN database. To access or add your site to the CTN database, click here.

The CTN works with industry partners through the Nuclear Medicine Clinical Trial Group, LLC.

Contact Information

The Clinical Trials Network would like to hear from you.

We are an organization of molecular imaging experts, from physicians and physicists to scientists and technologists. Many are pioneers in the field of nuclear medicine and molecular imaging. If you need assistance in incorporating molecular imaging into a therapeutic trial or want to study a new radiopharmaceutical, our team of experts can assist you with all phases of a clinical trial. From scanner validation, trial design assistance, and study personnel training, the CTN has programs to ensure that you are utilizing molecular imaging effectively and efficiently. To obtain more information about our specific programs or events, please contact us at [email protected].